Atlas Trials

Recurrent Uterine Corpus Sarcoma

12 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Recurrent Uterine Corpus Sarcoma

RecordFirmDate
Alisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus (NCT01637961)National Cancer Institute (NCI)2012-08-01
Trebananib And Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery (NCT01548482)National Cancer Institute (NCI)2012-03-01
Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer (NCT01247571)National Cancer Institute (NCI)2011-01-01
Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy (NCT01220609)National Cancer Institute (NCI)2010-11-01
Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer (NCT01168232)National Cancer Institute (NCI)2010-09-07
Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer (NCT01098630)Gynecologic Oncology Group2010-07-01
Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma (NCT01154452)National Cancer Institute (NCI)2010-06-01
Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma (NCT01012297)National Cancer Institute (NCI)2009-11-01
Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer (NCT00114218)Gynecologic Oncology Group2005-03-01
Thalidomide in Treating Patients With Recurrent or Persistent Cancer of the Uterus (NCT00025220)National Cancer Institute (NCI)2001-09-01
Thalidomide in Treating Patients With Recurrent or Persistent Carcinosarcoma of the Uterus (NCT00025506)National Cancer Institute (NCI)2001-09-01

Track Recurrent Uterine Corpus Sarcoma automatically

Every clearance here is in the API, with alerts when new ones post.